Leadership
Dinesh Mathottathil
Partner — Regulatory Affairs & Market Access
Regulatory Affairs · Licensing & Market Access · Pharma & Biologics · United Arab Emirates
Brought in when a pharmaceutical or biologics brand needs a UAE market entry to actually clear: registration, pricing, and licensing turned into an approval, on a timeline the business can plan around.
What he is brought in for
Dinesh Mathottathil has spent over 25 years in the UAE healthcare and pharmaceutical sector, working both sides of the market: the regulator and the brands. He has engaged closely with the Ministry of Health and Prevention (MOHAP) and with leading private-sector pharmaceutical and healthcare companies, which places him among the region's more experienced practitioners in pharmaceutical and biologics licensing.
His command runs the full value stream of UAE licensing for pharmaceuticals and biologics: early regulatory strategy and dossier preparation, through product registration, pricing approval, facility and trade licensing, and lifecycle maintenance. Clients move from filing to market with fewer delays and a clear line of sight on cost and timeline.
Across his career he has handled complex product registrations, establishment and facility licensing, import and controlled-substance permits, regulatory audits, and post-approval variations for a broad range of pharmaceutical and biologic products, paired with the commercial instinct to turn approvals into real presence across the UAE and the wider GCC.
Formation
Dinesh is a post-graduate in Pharmacy with advanced professional certification in regulatory affairs. His formation is on both sides of the UAE market: sustained engagement with MOHAP on the regulator's side, and licensing and market-access work for private-sector pharmaceutical and healthcare brands. That dual vantage is what lets him read a submission the way the authority will read it, and anticipate the question before it is asked.
How he works
He treats a licensing pathway as a project to be planned, not a queue to be waited in. Product classification and pathway determination come first, then dossier compilation, registration, pricing approval, facility and trade licensing, permits, and audit readiness, each sequenced so the next step is ready before the last one clears. The client always knows where the file stands and what it will cost to finish.
Planning a UAE or GCC market entry for a pharmaceutical or biologics brand? Start the licensing conversation with the person who will run it.